Medline Inc’s recent filing unveils that its 10% Owner Hellman & Friedman Capital Par unloaded Company’s shares for reported $172.72 million on Dec 18 ’25. In the deal valued at $28.37 per share,6,088,371 shares were sold. As a result of this transaction, Hellman & Friedman Capital Par now holds 4,806,160 shares worth roughly $212.19 million.
Then, GIC Private Ltd bought 12,586,206 shares, generating $364,999,974 in total proceeds. Upon buying the shares at $29.00, the 10% Owner now owns 27,241,378 shares.
Before that, GIC Private Ltd sold 10,204,351 shares. Medline Inc shares valued at $289,480,090 were divested by the 10% Owner at a price of $28.37 per share. As a result of the transaction, GIC Private Ltd now holds 91,555,447 shares, worth roughly $4.04 billion.
Wolfe Research initiated its Medline Inc [MDLN] rating to an Outperform in a research note published on January 12, 2026; the price target was $47. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in mid January with a ‘”an Outperform”‘ rating. Wells Fargo began covering MDLN with “an Equal weight” recommendation on January 12, 2026. UBS started covering the stock on January 12, 2026. It rated MDLN as “a Buy”.
Price Performance Review of MDLN
On Tuesday, Medline Inc [NASDAQ:MDLN] saw its stock jump 0.07% to $44.15. Over the last five days, the stock has gained 3.35%. Nevertheless, the stocks have risen 5.12% over the past one year.
The most recent change occurred on January 12, 2026 when Truist began covering the stock and recommended ‘”a Buy”‘ rating along with a $52 price target.
